Article Text

Download PDFPDF
Tackling acute coronary syndrome in low-income and middle-income countries
  1. Lucas Lodi-Junqueira1,
  2. Antonio Luiz Ribeiro1,2
  1. 1 Hospital das Clínicas and Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
  2. 2 National Institute of Science and Technology for Health Technology Assessment (IATS), Belo Horizonte, Brazil
  1. Correspondence to Professor Antonio Luiz Ribeiro, Centro de Telessaúde do Hospital das Clínicas da UFMG, Belo Horizonte, MG, Brazil; tom{at}, tom1963br{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Cardiovascular disease (CVD) is now the leading cause of mortality and morbidity worldwide, accounting for approximately one-third of all deaths globally.1 While popular belief presumes that non-communicable diseases (NCDs) afflict mostly high-income populations, the evidence tells a very different story. Nearly 80% of NCD deaths occur in low-income and middle-income countries (LMICs). Ischaemic heart disease (IHD) is the leading component of the global CVD burden.1 Mortality of IHD has decreased globally, especially in high-income countries (HICs), due to population-level changes in risk factors and to improvements in systems of care. Meanwhile, ageing of population, rapid economic growth, increasingly sedentary lifestyles and calorie-rich diets have increased the proportion of deaths attributable to CVD in many poorer regions of the world and, as a result, the mortality gap between LMIC and HIC over the past 20 years has narrowed.1

Improved systems of care, early detection and timely treatment are effective approaches for reducing the impact of CVD. However, appropriate care for people with NCDs is lacking in many settings, and access to essential technologies and medicines is limited, particularly in LMICs. In this context of scarce resources, it is imperative to get the most out of known effective interventions, such as the implementation of regional acute coronary syndrome (ACS) systems of care, lowering healthcare system delay (diagnosis, transportation and treatment), increasing reperfusion therapy and reducing in-hospital mortality.2 3

In their Heart manuscript, Galappatthy and colleagues4 presented the …

View Full Text


  • Contributors Both authors contributed equally to this article.

  • Funding This study was funded by Fundação de Amparo à Pesquisa do Estado de Minas Gerais (PPM-00428-17) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (465518/2014-1 and 310679/2016-8).

  • Competing interests None declared.

  • Patient consent Not required.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles

  • Coronary artery disease
    Priyadarshani Galappatthy Vipula R Bataduwaarachchi Priyanga Ranasinghe Gamini K S Galappatthy Maheshi Wijayabandara Dinuka S Warapitiya Mythily Sivapathasundaram Thilini Wickramarathna Upul Senarath Sathasivam Sridharan Chandrika N Wijeyaratne Ruvan Ekanayaka